The store will not work correctly when cookies are disabled.
N-(3-Pyridin-2-yl-isoquinolin-1-yl)-benzamidine
ID: ALA144665
PubChem CID: 6858772
Max Phase: Preclinical
Molecular Formula: C22H18N4
Molecular Weight: 338.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc2c(NC(=N)c3ccccn3)nc(-c3ccccc3)cc12
Standard InChI: InChI=1S/C22H18N4/c1-15-8-7-11-17-18(15)14-20(16-9-3-2-4-10-16)25-22(17)26-21(23)19-12-5-6-13-24-19/h2-14H,1H3,(H2,23,25,26)
Standard InChI Key: YJTXQOHZBUAFJX-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
4.8292 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8292 -4.3917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5500 -3.1542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5500 -4.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1167 -2.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5500 -2.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1167 -3.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8292 -1.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5500 -5.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2625 -6.0375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4042 -1.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2542 -1.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2625 -4.3917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4042 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6917 -3.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2667 -6.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6917 -2.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8292 -6.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4125 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2542 -1.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9750 -2.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5500 -7.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9625 -0.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8292 -6.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6875 -1.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6792 -1.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 2 1 0
5 7 2 0
6 3 1 0
7 1 1 0
8 5 1 0
9 4 1 0
10 9 2 0
11 5 1 0
12 6 1 0
13 4 2 0
14 7 1 0
15 14 2 0
16 10 1 0
17 15 1 0
18 9 1 0
19 11 1 0
20 12 2 0
21 12 1 0
22 24 1 0
23 20 1 0
24 18 2 0
25 21 2 0
26 25 1 0
8 6 2 0
17 11 2 0
26 23 2 0
16 22 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 338.41 | Molecular Weight (Monoisotopic): 338.1531 | AlogP: 5.04 | #Rotatable Bonds: 3 |
Polar Surface Area: 61.66 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 4.15 | CX LogP: 5.16 | CX LogD: 5.16 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.41 | Np Likeness Score: -0.80 |
References
1. de Zwart MA, van der Goot H, Timmerman H.. (1989) Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 2. Amidines., 32 (2): [PMID:2913309] [10.1021/jm00122a033] |